European Union Drugs Agency (EUDA)

What European Union Drugs Agency (EUDA) does

The European Union Drugs Agency (EUDA) is a decentralised agency of the European Union, headquartered in Lisbon, Portugal, that provides authoritative, evidence-based information on drugs and drug-related harms across Europe. It succeeded the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), operational since 1993, on 2 July 2024 pursuant to Regulation (EU) 2023/1322. EUDA's mandate is to collect, analyse, and disseminate harmonised data on illicit drug use, harms, and supply for the 27 EU Member States plus Türkiye and Norway, drawing on the Reitox network of national focal points and a suite of specialist scientific networks covering wastewater analysis (SCORE), drug checking (TEDI), hospital emergencies (Euro-DEN Plus), syringe residues (ESCAPE), and forensic and toxicological laboratories.

EUDA's core outputs are the annual European Drug Report and Statistical Bulletin, which together provide national- and city-level indicators on prevalence, treatment demand, drug-induced deaths, infectious diseases, seizures, and prices/purity. The EU Early Warning System on New Psychoactive Substances, operating since 1997 in cooperation with Europol and the European Medicines Agency, has formally notified more than 860 NPS. The agency also publishes the European Responses Guide, modular EU Drug Markets analyses produced jointly with Europol, drug profiles, threat assessments (including on highly potent synthetic opioids), and training curricula such as the European Prevention Curriculum delivered via the PLATO learning platform. An open Data Catalogue of 148 datasets, released under Creative Commons Attribution 4.0, makes all outputs freely available.

EUDA is funded directly from the European Union budget and generates no commercial revenue; all outputs are publicly available at no cost. Its stakeholders include EU institutions (European Parliament, Council, Commission), national governments, healthcare professionals, law enforcement agencies, researchers, and the general public. Its predecessor agency, the EMCDDA, was established in 1993; the transition to EUDA in 2024 broadened the agency's scope to strengthen health and security preparedness, exemplified by the launch of the EUDA Network of forensic and toxicological laboratories in November 2024.

Name

European Union Drugs Agency (EUDA)

Legal name

European Union Drugs Agency (EUDA)

Website

https://euda.europa.eu

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

101–250 employees

Short description

The European Union Drugs Agency (EUDA) is an EU decentralised agency, headquartered in Lisbon, that collects, analyses, and disseminates evidence on illicit drugs, related harms, and supply across 29 reporting countries for EU institutions, Member State governments, healthcare professionals, law enforcement, and researchers.

Ownership category

akta.pro rank

Product category

Public Health Drug Monitoring Services

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615), Administration of Economic Programs (9261), Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (926150)

SIC

International Affairs (9721), Services-Membership Organizations (8600)

akta.pro primary industry

Controlled Substances & Narcotics Regulators (HLAJADAK)

akta.pro secondary industries

Controlled Substances & Pharmacy Regulation Authorities (HLAJACAI), Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED) (HLAJAJAM)

Keywords

• Drug monitoring services
• Public health intelligence
• Early warning systems
• Epidemiological research
• Harm reduction guidance

Headquarters

HQ city

Lisbon

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. EU Public Funding: EUDA is funded by the European Union budget as a decentralised agency. The agency does not generate commercial revenue.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

EUDA collects, analyzes, and disseminates evidence-based data on the drug situation across Europe through annual reports, statistical bulletins, an early warning system for new psychoactive substances, and specialized monitoring networks. The agency serves EU Member States, candidate countries, and partner countries with drug-related intelligence for policy development, public health responses, law enforcement cooperation, and academic research.

Product overview

The European Union Drugs Agency (EUDA) operates as a decentralized EU agency offering a comprehensive suite of data, analysis, and evidence-based resources on the drug situation in Europe. The core portfolio centers on the Statistical Bulletin (annual data on drug use prevalence, treatment, deaths, and market indicators), the European Drug Report (annual trend analysis across 14 thematic areas), and the EU Early Warning System (monitoring new psychoactive substances since 1997). Supporting these are the European Responses Guide (practical guidance for interventions), EU Drug Markets analysis (modular drug-specific market studies), and the Reitox Network (29 national focal points providing country data). The EUDA also maintains specialized networks including the Network of Labs (forensic and toxicological laboratories), TEDI (drug checking), Euro-DEN Plus (hospital emergencies), ESCAPE (syringe analysis), and SCORE (wastewater analysis). Data is accessible through the Data Catalogue, with interactive visualization tools and dashboards. The agency also provides training through the European Prevention Curriculum and operates the PLATO learning platform. All published data is released under Creative Commons Attribution 4.0 license.

Differentiator

Problem solved

Functional benefit

Products and services

• Statistical Bulletin Annual comprehensive data publication containing national-level indicators on drug-use prevalence, treatment demand, drug-induced deaths, infectious diseases, seizures, prices, purity and more, complemented by city-level metrics from specialist networks. Available in interactive online format and downloadable CSV.
• European Drug Report 2026 Comprehensive annual analysis of the drug situation in Europe, covering illicit drug use, related harms and drug supply. Contains 14 thematic modules including cannabis, cocaine, opioids, NPS, and harm reduction interventions.
• EU Early Warning System (EWS) on New Psychoactive Substances Multiagency and multidisciplinary network operating since 1997 to detect, assess, and respond to new psychoactive substances. Monitors over 860 NPS formally notified, comprising EUDA, 29 national early warning systems, Europol, EMA, and European Commission.
• European Responses Guide

Quantifiable outcome

• 29 countries providing annual data for European Drug Report 2026
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

23 partnerships are on record, tiered core, major and supporting.

• EuropolcoreStrategic or Co-development PartnerClose cooperation on EU Drug Markets analysis, Early Warning System operations, and EMPACT (European Multidisciplinary Platform Against Criminal Threats). The fourth comprehensive EU Drug Markets overview produced jointly by EUDA and Europol with support of EU Member States.
• Reitox NetworkcoreStrategic or Co-development PartnerEuropean information network on drugs comprising national focal points in the 27 EU Member States, Türkiye, Norway, and the European Commission. Responsible for providing national drug information to EUDA.
• European Medicines Agency (EMA)coreStrategic or Co-development PartnerProvides information on whether NPS are used as active substances in medicinal products for human or veterinary use. Part of the EU Early Warning System network.
• European Centre for Disease Prevention and Control (ECDC)coreStrategic or Co-development PartnerCollaboration on drug-related infectious diseases data and responses. ECDC receives incidence data on drug-related HIV and hepatitis from EUDA.
• United Nations Office on Drugs and Crime (UNODC)majorStrategic or Co-development PartnerInternational cooperation on global drug monitoring, data sharing, and policy alignment. UNODC data sources complement EUDA analysis.
• European Chemicals Agency (ECHA)supportingTechnology or IntegrationProvides information and data on NPS within ECHA's remit as part of the Early Warning System contributions.
• European Food Safety Authority (EFSA)supportingTechnology or IntegrationProvides available information and data on NPS as part of the multi-agency risk assessment process.
• European CommissioncoreStrategic or Co-development PartnerPrimary EU institutional partner providing funding, policy direction, and receiving EUDA outputs for regulatory and legislative action. Operates under Regulation (EU) 2023/1322.
• EU Agency for Law Enforcement Training (CEPOL)supportingStrategic or Co-development PartnerCooperation on law enforcement training related to drug issues, part of the EU Drug Markets analysis acknowledgements.
• EU Agency for Judicial Cooperation (Eurojust)supportingStrategic or Co-development PartnerCooperation on judicial aspects of drug crime, acknowledged in EU Drug Markets analysis.
• European Border and Coast Guard Agency (Frontex)supportingStrategic or Co-development PartnerBorder security cooperation relevant to drug trafficking prevention, acknowledged in EU Drug Markets analysis.
• World Customs Organisation (WCO)supportingStrategic or Co-development PartnerInternational customs cooperation for drug trafficking prevention, acknowledged in EU Drug Markets analysis.
• International Narcotics Control Board (INCB)supportingStrategic or Co-development PartnerGlobal drug control cooperation, with INCB data complementing EUDA analysis.
• World Health Organization Regional Office for Europe (WHO Europe)majorStrategic or Co-development PartnerPublic health cooperation on drug-related issues including harm reduction and infectious disease prevention.
• InterpolsupportingStrategic or Co-development PartnerInternational law enforcement coordination on drug crime beyond EU borders.
• European School Survey Project on Alcohol and Other Drugs (ESPAD)coreStrategic or Co-development PartnerCollaboration on school survey data providing prevalence information on substance use among young people in Europe.
• Joint Research Centre (JRC)coreTechnology or IntegrationRepresents the European Commission in the Network of forensic and toxicological laboratories. Provides independent, evidence-based knowledge and science support.
• Sewage Analysis Core Group Europe (SCORE)coreStrategic or Co-development PartnerCity-level wastewater analysis network providing complementary drug consumption data to national reported data sets.
• Trans-European Drug Information Network (TEDI)coreStrategic or Co-development PartnerNetwork providing drug checking data from across Europe, operating as part of the city-level data collection alongside Statistical Bulletin.
• European Drug Emergencies Network (Euro-DEN Plus)coreStrategic or Co-development PartnerNetwork monitoring acute drug-toxicity presentations to emergency services, providing hospital emergencies data at city level.
• European Syringe Collection and Analysis Project Enterprise (ESCAPE)coreStrategic or Co-development PartnerNetwork analysing syringe residues to monitor injecting drug use patterns in Europe, providing city-level data.
• Pompidou Group of the Council of EuropesupportingStrategic or Co-development PartnerCouncil of Europe intergovernmental cooperation group dealing with drug policy issues.
• European Network of Drug Consumption Rooms (ENDCR)supportingStrategic or Co-development PartnerNetwork of drug consumption rooms providing harm reduction data and best practice exchange.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Europol: EU law enforcement agency with which EUDA jointly produces the EU Drug Markets analysis and operates the Early Warning System. Europol is a core strategic partner whose enforcement intelligence complements EUDA's public health monitoring.
• European Centre for Disease Prevention and Control (ECDC): Fellow EU decentralised agency operating in public health surveillance. ECDC produces comparable epidemiological outputs (annual reports, data catalogues, threat assessments) and shares Member-State reporting infrastructure with EUDA, including joint work on drug-related infectious diseases.
• United Nations Office on Drugs and Crime (UNODC): The UN's global drug monitoring body, directly comparable to EUDA in mandate (drug monitoring, data publication, early warning). UNODC operates at global scale while EUDA covers Europe, but their functions—annual reports, thematic analyses, and policy advisory—are closely aligned.

Regional players

• Pompidou Group of the Council of Europe: Council of Europe intergovernmental cooperation group on drug policy and addiction. Operates as a broader European (non-EU) policy platform that complements EUDA's work on drug policy exchange, particularly with non-EU Member States.

Broad incumbents

• US National Institute on Drug Abuse (NIDA): US federal agency funding and conducting drug use research, publishing national data on substance use trends. NIDA operates as a research and surveillance counterpart to EUDA in the US, with comparable public-facing reports and data publishing functions.
• World Health Organization Regional Office for Europe (WHO Europe): WHO's European regional office produces public health data, treatment guidelines, and reports on substance use. It is a long-standing EUDA partner on harm reduction and infectious disease, with overlapping functions in health surveillance and policy support.
• European Medicines Agency (EMA): EU decentralised agency providing regulatory oversight on pharmaceuticals, including active substances in new psychoactive substances. EMA is a member of EUDA's Early Warning System and complements EUDA's monitoring work with regulatory decision-making on medicines.
• US Centers for Disease Control and Prevention (CDC): US federal public health agency publishing surveillance data, including on drug overdose and infectious disease. Operates analogous surveillance and reporting functions to EUDA, particularly through its Overdose Data to Action program.

Others

• European Chemicals Agency (ECHA): EU agency regulating chemicals that contributes data to EUDA's Early Warning System on new psychoactive substances. Functionally adjacent—providing chemical and precursor substance information that supports EUDA's surveillance activities.
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Archive: EUDA's predecessor agency, providing historical context through its archived web presence. While not a current operating peer, the EMCDDA's archived outputs represent EUDA's legacy and show the methodological continuity of EU drug monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/EUDrugsAgency
• YouTubeyoutube.com/@eudrugsagency
• Facebookfacebook.com/EUDrugsAgency
• LinkedInlinkedin.com/company/eudrugsagency
• Instagraminstagram.com/eudrugsagency

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Union Drugs Agency (EUDA)